Hematology New Patient Consultation Note (Outpatient)

Date of Service: [Date]

Encounter Type: New Patient Hematology Consultation - Outpatient

Clinic/Location: [Clinic or location]

Mode: [in-person / telehealth]

Referring Clinician: [Name, specialty, organization] (If unknown: "Referring clinician not specified; to be clarified.")

Primary Care Clinician: [Name] (If unknown, omit this line.)

History Provided By: [patient / caregiver / interpreter] (If interpreter used, specify language and modality.)

Reason for Consultation

[Reason for referral] (State succinctly. If multiple questions, list and number them. Include urgency or timing constraints such as pre-operative deadlines if applicable.)

Records Reviewed

• [Source institution/clinician, dates]: [Document types reviewed] (Specify whether original reports, portal printouts, or faxed summaries.)
• [Records requested but not yet available]: [What was requested, why it matters, current status] (Include only if applicable.)
• [Discrepancies between patient report and documentation] (Note neutrally; include only if present.)

History of Present Illness

[Narrative HPI, 1–3 paragraphs] (Open with consult focus. Include timeline with onset, progression, and key turning points; prior evaluations and treatments with responses; and current symptoms. For bleeding concerns: site, frequency, severity, triggers, procedural/surgical/dental/postpartum history. For thrombosis: dates, provoking factors, anticoagulation history, complications. For anemia: exertional tolerance, pica, restless legs, chest pain. For suspected malignancy: B symptoms, lymphadenopathy symptoms, early satiety, bone pain. Include pertinent negatives aligned to the differential. Document uncertainty and verification attempts when patient cannot recall key details.)

Past Medical and Surgical History

• [Conditions impacting differential, bleeding/thrombosis risk, marrow reserve, or treatment selection]
• [Autoimmune, renal, hepatic, or prior malignancy history]
• [Major surgeries with dates, especially GI/bariatric affecting absorption or bleeding risk]

Medications

• Anticoagulants/Antiplatelets: [Medication, dose, indication, adherence, last dose if procedure planning]
• Hematology-relevant therapies: [Chemotherapy, immunosuppressants, growth factors]
• Supplements: [Iron, B12, folate with formulation, dose, adherence]
• Other medications: [List or attach reconciled list] (Note hematology-relevant interactions if applicable. If reconciliation incomplete: "Medication reconciliation incomplete; to be confirmed.")

Allergies

• [Allergen] — [Reaction type/severity]
• [Transfusion reactions with product type and reaction details] (Include only if applicable.)

Family History

• [Hematologic malignancies]
• [Bleeding disorders]
• [Venous/arterial thrombosis with age at first event]
• [Anemia, hemolysis, or hemoglobinopathies]

Social History

• [Tobacco use]
• [Alcohol use]
• [Occupation and exposures]
• [Dietary patterns if relevant to anemia]
• [Social factors affecting plan feasibility] (Include only if relevant.)

Review of Systems

(Targeted to hematology-relevant systems; keep brief. Omit section entirely if duplicative of HPI.)

• [Constitutional: fevers, night sweats, weight change, fatigue]
• [HEENT: epistaxis, mucosal bleeding, dental bleeding]
• [Cardiovascular/Respiratory: chest pain, dyspnea]
• [GI/GU: melena, hematochezia, hematuria, menorrhagia]
• [Skin: petechiae, purpura, ecchymoses]
• [Neuro: headaches, focal deficits] (Include only if bleeding risk or CNS concern.)

Physical Examination

(If telehealth with limited exam, state limitations explicitly.)

• General: [Appearance, distress, pallor, cachexia]
• Vital signs: [Vitals] (Include only if available.)
• HEENT: [Conjunctival pallor, scleral icterus, oral mucosa]
• Lymph nodes: [Cervical, axillary, inguinal—size, character, tenderness]
• Cardiovascular: [Rate, rhythm, murmurs]
• Abdomen: [Hepatomegaly, splenomegaly, exam limitations]
• Skin: [Petechiae, purpura, ecchymoses]
• Extremities: [Edema, DVT signs]
• Neurologic: [Focal deficits, mental status] (Include only if bleeding risk or CNS concern.)

Diagnostics

(Include only completed results informing the differential or plan. Clearly label outside reports. Present trends when pattern recognition matters.)

• CBC trends:
  • [Date]: WBC [value], Hgb/Hct [value/value], MCV [value], Plt [value]
  • [Date]: WBC [value], Hgb/Hct [value/value], MCV [value], Plt [value]
• Reticulocyte count: [Value, date]
• Hemolysis markers: [LDH, haptoglobin, indirect bilirubin, DAT with dates]
• Iron studies: [Ferritin, iron, TIBC, TSAT with dates]
• B12/Folate: [Values, dates]
• Coagulation studies: [PT/INR, aPTT, fibrinogen]
• Monoclonal protein evaluation: [SPEP/IFE, free light chains] (Include only if applicable.)
• Peripheral smear: [Personally reviewed / Based on outside report] — [Key morphologic findings]
• Imaging: [Modality, date, key findings]
• Pathology: [Bone marrow, flow cytometry, cytogenetics, molecular] (Label as outside report if applicable; summarize salient findings.)
• Pending results: [Test, expected turnaround, decisions contingent on results]

Synthesis

[Interpretive summary] (1–2 concise paragraphs. State the unifying pattern, degree of certainty with reasoning, how discordant findings are reconciled, and explicit limitations from missing data or pending results.)

Assessment

(Problem-oriented; list the referral problem first. Document uncertainty when data are insufficient.)

[Problem 1]: [Leading impression]

[Focused differential with brief supporting/refuting points. Severity or risk framing. Key data gaps affecting decisions.]

[Problem 2]: [Leading impression]

[As above] (Include additional problems in order of clinical urgency. Omit if single-problem consultation.)

Plan

(Organize by problem. Be specific and actionable.)

[Problem 1]

• Diagnostics: [Tests to order now; contingent next steps based on possible results]
• Therapeutics: [Medications with dose/route/frequency; transfusion strategy; supportive care]
• Monitoring and safety: [Lab frequency, ED thresholds, callback triggers]
• Counseling: [Key discussion points, shared decisions, patient preferences]
• Follow-up: [Timing and required pre-visit completions]

[Problem 2]

• Diagnostics: [As above]
• Therapeutics: [As above]
• Monitoring and safety: [As above]
• Counseling: [As above]
• Follow-up: [As above]

(When critical elements are missing, document what is missing, why it matters, steps taken to obtain it, and interim management.)

Communication to Referring Clinician

[One-sentence case summary. Direct answers to each referral question. Key diagnostic and therapeutic recommendations with timing. Requests for specific actions from referring team. Plan for updates and communication timeline.]

Orders and Coordination

• [Laboratory and imaging orders placed]
• [Referrals or consults placed]
• [Pathology material requests, e.g., outside slides/blocks]
• [Medical records requests and status]
• [Follow-up appointment scheduling]